{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T16:24:47Z","timestamp":1777566287186,"version":"3.51.4"},"reference-count":20,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002261","name":"Russian Foundation for Basic Research","doi-asserted-by":"publisher","award":["15-04-05286"],"award-info":[{"award-number":["15-04-05286"]}],"id":[{"id":"10.13039\/501100002261","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003443","name":"Ministry of Education and Science of the Russian Federation","doi-asserted-by":"publisher","award":["14.616.21.0065"],"award-info":[{"award-number":["14.616.21.0065"]}],"id":[{"id":"10.13039\/501100003443","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003443","name":"Ministry of Education and Science of the Russian Federation","doi-asserted-by":"publisher","award":["RFMEFI61616X0065"],"award-info":[{"award-number":["RFMEFI61616X0065"]}],"id":[{"id":"10.13039\/501100003443","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.jiac.2017.04.012","type":"journal-article","created":{"date-parts":[[2017,5,18]],"date-time":"2017-05-18T01:16:03Z","timestamp":1495070163000},"page":"794-797","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["New 1-hydroxy-2-thiopyridine derivatives active against both replicating and dormant Mycobacterium tuberculosis"],"prefix":"10.1016","volume":"23","author":[{"given":"Elena G.","family":"Salina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Ryabova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Vocat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boris","family":"Nikonenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stewart T.","family":"Cole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vadim","family":"Makarov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2017.04.012_bib1","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1473-3099(13)70328-1","article-title":"New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospects","volume":"4","author":"Zumla","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jiac.2017.04.012_bib2","series-title":"Global tuberculosis report","year":"2016"},{"key":"10.1016\/j.jiac.2017.04.012_bib3","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.tube.2010.03.008","article-title":"Drug-resistant tuberculosis in the European Union: opportunities and challenges for control","volume":"90","author":"Fears","year":"2010","journal-title":"Tuberc (Edinb)"},{"key":"10.1016\/j.jiac.2017.04.012_bib4","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/S0140-6736(06)68384-0","article-title":"Global epidemiology of tuberculosis","volume":"367","author":"Dye","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.jiac.2017.04.012_bib5","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.2741\/1291","article-title":"Persistent and dormant tubercle bacilli and latent tuberculosis","volume":"9","author":"Zhang","year":"2004","journal-title":"Front Biosci"},{"key":"10.1016\/j.jiac.2017.04.012_bib6","first-page":"140","article-title":"Zinc pyrithione: a topical antimicrobial with complex pharmaceutics","volume":"15","author":"Schwartz","year":"2016","journal-title":"J\u00a0Drugs Dermatol"},{"key":"10.1016\/j.jiac.2017.04.012_bib7","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1128\/AAC.01308-13","article-title":"New 2-thiopyridines as potential candidates for killing both actively growing and dormant Mycobacterium tuberculosis cells","volume":"58","author":"Salina","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2017.04.012_bib8","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1128\/AAC.46.8.2720-2722.2002","article-title":"Resazurin microtiter assay plate: simple and inexpensive method for detection of drug resistance in Mycobacterium tuberculosis","volume":"46","author":"Palomino","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2017.04.012_bib9","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1128\/AAC.00821-10","article-title":"Simple model for testing drugs against nonreplicating Mycobacterium tuberculosis","volume":"54","author":"Sala","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2017.04.012_bib10","doi-asserted-by":"crossref","first-page":"6422","DOI":"10.1128\/AAC.00998-16","article-title":"In\u00a0vitro activity of 3-Triazeneindoles against Mycobacterium tuberculosis and Mycobacterium avium","volume":"60","author":"Nikonenko","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2017.04.012_bib11","doi-asserted-by":"crossref","first-page":"5782","DOI":"10.1128\/AAC.01125-12","article-title":"Streptomycin-starved Mycobacterium tuberculosis 18b, a drug discovery tool for latent tuberculosis","volume":"56","author":"Zhang","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2017.04.012_bib12","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1128\/AAC.02410-14","article-title":"In\u00a0vitro and in\u00a0vivo activities of three oxazolidinones against nonreplicating Mycobacterium tuberculosis","volume":"58","author":"Zhang","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2017.04.012_bib13","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1128\/iai.64.6.2062-2069.1996","article-title":"An in\u00a0vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence","volume":"64","author":"Wayne","year":"1996","journal-title":"Infect Immun"},{"key":"10.1016\/j.jiac.2017.04.012_bib14","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1046\/j.1365-2958.2002.02779.x","article-title":"Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling","volume":"43","author":"Betts","year":"2002","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.jiac.2017.04.012_bib15","first-page":"67","article-title":"The probability of most probable numbers","volume":"1","author":"de Man","year":"1975","journal-title":"J\u00a0Appl Microbiol"},{"key":"10.1016\/j.jiac.2017.04.012_bib16","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nchembio884","article-title":"Diarylquinolines target subunit c of mycobacterial ATP synthase","volume":"3","author":"Koul","year":"2007","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.jiac.2017.04.012_bib17","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1126\/science.1171583","article-title":"Benzothiazinones kill Mycobacterium tuberculosis by blocking arabinan synthesis","volume":"324","author":"Makarov","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.jiac.2017.04.012_bib18","doi-asserted-by":"crossref","DOI":"10.2174\/0929867324666170208150016","article-title":"Molecular players in Tuberculosis drug development: another break in the cell wall","author":"Squeglia","year":"2017","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.jiac.2017.04.012_bib19","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1021\/cb500149m","article-title":"Rv2466c mediates the activation of TP053 to kill replicating and non-replicating Mycobacterium tuberculosis","volume":"9","author":"Albesa-Jov\u00e9","year":"2014","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.jiac.2017.04.012_bib20","doi-asserted-by":"crossref","first-page":"4093","DOI":"10.1021\/jm4003878","article-title":"Preliminary structure-activity relationships and biological evaluation of novel antitubercular indolecarboxamide derivatives against drug-susceptible and drug-resistant Mycobacterium tuberculosis strains","volume":"56","author":"Onajole","year":"2013","journal-title":"J\u00a0Med Chem"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X17300971?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X17300971?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:57:03Z","timestamp":1761159423000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X17300971"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":20,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S1341321X17300971"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2017.04.012","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New 1-hydroxy-2-thiopyridine derivatives active against both replicating and dormant Mycobacterium tuberculosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2017.04.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}